PFG Investments LLC Purchases 661 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

PFG Investments LLC lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 7.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,319 shares of the financial services provider’s stock after acquiring an additional 661 shares during the period. PFG Investments LLC’s holdings in iShares Biotechnology ETF were worth $1,232,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in IBB. Hsbc Holdings PLC boosted its holdings in iShares Biotechnology ETF by 47.1% in the second quarter. Hsbc Holdings PLC now owns 3,670 shares of the financial services provider’s stock worth $504,000 after purchasing an additional 1,175 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of iShares Biotechnology ETF by 2.6% in the 2nd quarter. Bank of Montreal Can now owns 36,198 shares of the financial services provider’s stock worth $5,086,000 after buying an additional 920 shares during the last quarter. Creative Planning grew its holdings in shares of iShares Biotechnology ETF by 2.9% in the second quarter. Creative Planning now owns 67,902 shares of the financial services provider’s stock worth $9,320,000 after acquiring an additional 1,905 shares during the period. NewEdge Advisors LLC increased its position in iShares Biotechnology ETF by 20.1% during the second quarter. NewEdge Advisors LLC now owns 11,633 shares of the financial services provider’s stock valued at $1,597,000 after acquiring an additional 1,944 shares during the last quarter. Finally, B. Riley Wealth Advisors Inc. lifted its holdings in iShares Biotechnology ETF by 2.0% in the second quarter. B. Riley Wealth Advisors Inc. now owns 11,722 shares of the financial services provider’s stock valued at $1,609,000 after acquiring an additional 229 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.8 %

Shares of NASDAQ:IBB opened at $138.37 on Tuesday. The firm’s 50 day moving average price is $136.15 and its 200-day moving average price is $141.77. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.